Oxford Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-57,730
| Closed | -$1.27M | – | 1577 |
|
|
2019
Q4 | $1.27M | Buy |
+57,730
| New | +$1.27M | 0.04% | 713 |
|
|
2018
Q4 | – | Sell |
-49,661
| Closed | -$761K | – | 2214 |
|
|
2018
Q3 | $761K | Buy |
49,661
+5,098
| +11% | +$78.1K | 0.02% | 1134 |
|
|
2018
Q2 | $539K | Sell |
44,563
-144,731
| -76% | -$1.75M | 0.01% | 1312 |
|
|
2018
Q1 | $1.81M | Buy |
189,294
+136,132
| +256% | +$1.3M | 0.04% | 627 |
|
|
2017
Q4 | $498K | Buy |
+53,162
| New | +$498K | 0.01% | 1180 |
|
|
2016
Q4 | – | Sell |
-59,006
| Closed | -$347K | – | 906 |
|
|
2016
Q3 | $347K | Sell |
59,006
-227,407
| -79% | -$1.34M | 0.01% | 653 |
|
|
2016
Q2 | $859K | Buy |
286,413
+149,560
| +109% | +$449K | 0.03% | 513 |
|
|
2016
Q1 | $734K | Buy |
136,853
+120,260
| +725% | +$645K | 0.02% | 543 |
|
|
2015
Q4 | $198K | Buy |
+16,593
| New | +$198K | ﹤0.01% | 798 |
|